• Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Drugs

Drugs

Page 28 of 30

Inside of a Gilead Sciences Lab
Tech

Drugmaker Alexion boosts its rare drug pipeline with $8.4 billion deal

By Reuters
May 6, 2015
PA: Mylan Headquarters
Finance

Mylan goes big with $29 billion offer to buy Perrigo

By Laura Lorenzetti
April 8, 2015
States ask U.S. Congress to launch inquiry of herbal supplements
Retail

States ask U.S. Congress to launch inquiry of herbal supplements

By Reuters
April 2, 2015
IL: Corporations In Illinois
International

Takeda’s ready to shell out $2.2 billion to settle Actos drug cases

By Laura Lorenzetti
April 1, 2015
Where do CEOs with addictions go when they hit bottom?
Leadership

Where do CEOs with addictions go when they hit bottom?

By Daniel Bukszpan
March 25, 2015
Merck
Features

Merck halts study in light of melanoma drug’s success

By Laura Lorenzetti
March 24, 2015
George Scangos, CEO of Biogen Inc. speaks during Reuters Health Summit in New York
Features

How Biogen scored the most successful Alzheimer’s drug so far

By Jen Wieczner
March 21, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance

Valeant comes out a winner after upping its Salix bid to $11.1 billion

By Laura Lorenzetti
March 16, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
Features

FDA approves the first biosimilar for the U.S. market

By Laura Lorenzetti
March 6, 2015
IL: Corporations In Illinois
Finance

AbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal

By Reuters
March 5, 2015
Inside Rite Aid Ahead of Earnings Reports
Retail

Rite Aid takes aim at CVS with a $2 billion purchase

By Laura Lorenzetti
February 11, 2015
161135392
Features

Biosimilars may one day save your life. But what are they?

By Laura Lorenzetti
February 6, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance

After Allergan loss, is Valeant dumpster diving?

By Jen Wieczner
January 31, 2015
Picture taken on January 15, 2012 in Lil

How to stop generic drug shortages: end hospital group purchasing kickbacks 

By Phillip L. Zweig and Robert A. Campbell
January 30, 2015
Los Angeles City Council Votes To Ban Medical Marijuana Dispensaries

Report predicts 18 states will legalize pot by 2020

By TIME
January 26, 2015

Most Popular

  • AI
    A man let ChatGPT sell his home. It beat every agent's estimate by $100K—and closed in 5 days
    By Jake Angelo
  • Success
    Covid gave us hybrid work. The Iran War might give us a four-day week—and this time, experts say it could stick
    By Orianna Rosa Royle
  • Real Estate
    Gen Z can’t afford a house. Some parents are choosing to fund their down payments over their college funds
    By Jake Angelo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.